Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04646356 |
|
Recruitment Status :
Recruiting
First Posted : November 27, 2020
Last Update Posted : November 14, 2022
|
Sponsor:
Unity Health Toronto
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
Unity Health Toronto
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2023 |
| Estimated Study Completion Date : | September 2024 |